2018’s Annual Meeting of the American Society of Hematology proved to be a big year for research in the myeloproliferative neoplasms. Tens of thousands of experts in blood disorders in attendance proved that work in the MPNs is vigorous and ongoing.
Our Scientific Advisor John Crispino, PhD, from Northwestern University, took part in the meeting. He’s reported back exclusively to us on what you need to know as a patient, caregiver, community hematologist or anyone working in the MPNs.
This report will focus on four areas from the ASH presentations:
JAK inhibitor Clinical Updates
New Mechanisms of Action, clinical updates
Notable Basic Science Reports
Fill out the form below to download the full report: